Imperial’s President, Professor Alice Gast, welcomed Dr Ashton Carter and UK Secretary of State for Defence, Michael Fallon, to the College on Friday 9 October.
To stop publicly-funded research sinking in the valley of death, it is essential to bring industry and universities together in centres dedicated to commercialisation, according to Mike Gregory and Roman Szumski, experts from the UK and Canada
ITER will be the biggest-ever fusion device generating a plasma whose volume will be close to 840 m3 at 150 million ˚ C, ten times the temperatures at the core of the sun. To achieve these temperatures we would need powerful heating systems using high-energy beams, in order to push together the nuclei and trigger off a fusion reaction.
With a government spending review looming, the research lobby is out to make the case for protecting the R&D budget. Here, Hayaatun Sillem of the Royal Academy of Engineering argues an increase in public R&D will pull in more private investment
Draft work plans for 2016 and 2017 are out, with ambitions to replace animal testing, resist the rising tide of antimicrobial resistance and deliver faster internet speeds
Clever intellectual property (IP) management and carefully designed government policies can help SMEs raise more finance, reducing the risk for banks and venture capital investors, according to new Science|Business reports
King's College London is one of 10 universities that has been awarded funding from Research Councils UK (RCUK) as part of the new Public Engagement with Research Catalyst Seed Fund (CSF).
Research lobbyists gathered in Brussels to tell the European Commission what they like and what is niggling them about the €77B research programme to date
One of the best features of Horizon 2020 risks becoming its fatal flaw. Open-ended competitions have resulted in a flood of doomed applications, some 80 pages in length. Proposals should be shorter, and call topics tightened
A new Science|Business analysis puts the spotlight on the most innovative clusters in Europe, uncovering what it takes to translate research from bench to bedside and highlighting the crucial need for policy support, innovation pull, and access to finance
UK pharma company jumps on the open access R&D bandwagon, offering access to data on over 50 of its drugs, with the aim of inspiring new combination therapies for cancer
On 17 September 2015, the President and Director of the COST Association had a first meeting with the Commissioner for Research, Science and Innovation, Carlos Moedas, discussing COST’s role in promoting open science and open innovation across Europe
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.